CytoDyn Inc (CYDY.PK)

CYDY.PK on OTC Markets Group

0.84USD
27 Feb 2015
Change (% chg)

$0.05 (+6.33%)
Prev Close
$0.79
Open
$0.80
Day's High
$0.84
Day's Low
$0.78
Volume
247,482
Avg. Vol
76,377
52-wk High
$1.30
52-wk Low
$0.54

CYDY.PK

Chart for CYDY.PK

About

CytoDyn Inc. is a biotechnology company focused on discovering and developing a class of therapeutic monoclonal antibodies to treats Human Immunodeficiency Virus (HIV) infection. Its lead product candidate, PRO 140, belongs to a class of HIV therapies known as entry inhibitors. These therapies potentially block HIV from entering... (more)
No analyst recommendations are available for CYDY.PK.

Overall

Beta: 2.48
Market Cap(Mil.): $46.40
Shares Outstanding(Mil.): 58.73
Dividend: --
Yield (%): --

Financials

  CYDY.PK Industry Sector
P/E (TTM): -- 175.70 40.21
EPS (TTM): -0.26 -- --
ROI: -239.21 -2.61 16.34
ROE: -402.99 -4.38 17.27
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Factual Report
$138.00
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: GlobalData
$125.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks